Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970–98
Article first published online: 15 JUL 2005
Volume 100, Issue 9, pages 1249–1257, September 2005
How to Cite
Humphreys, K., Weingardt, K. R., Horst, D., Joshi, A. A. and Finney, J. W. (2005), Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970–98. Addiction, 100: 1249–1257. doi: 10.1111/j.1360-0443.2005.01175.x
- Issue published online: 15 JUL 2005
- Article first published online: 15 JUL 2005
- Submitted 22 September 2004; initial review completed 15 December 2004; final version accepted 18 April 2005
Aims To describe the eligibility criteria (i.e. study participant inclusion and exclusion rules) employed in alcohol treatment outcome research and to identify predictors of their use.
Design The eligibility criteria of 683 alcohol treatment outcome studies conducted between 1970 and 1998 were coded reliably into 14 general categories. Predictors of the use of eligibility criteria were then examined.
Findings Patients were most often ruled ineligible for research studies because of their level of alcohol problems (39.1% of studies), comorbid psychiatric problems (37.8%), past or concurrent utilization of alcohol treatment (31.8%), co-occurring medical conditions (31.6%), and because they were deemed non-compliant and unmotivated (31.5%). The number of eligibility criteria employed in studies increased from the 1970s through the 1990s, and was positively associated with funding from the US National Institute of Alcohol Abuse and Alcoholism (NIAAA) and from the private sector, lack of an inpatient/residential treatment condition, presence of a pharmacotherapy, and use of a randomized, multiple-condition design. Principal investigators with doctoral degrees used more eligibility criteria than those with lower degrees.
Conclusion Participant eligibility criteria are extensively employed in alcohol treatment outcome research, and vary significantly across historical periods, funders and research designs. Researchers should report the details of subject eligibility criteria and excluded patients more fully, and, evaluate how eligibility criteria affect the cost, feasibility, and generalizability of treatment outcome research.